Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | LPL | P06858 | 2/20 | 0.45 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.45 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | PLK1 | P53350 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | CTDSP1 | Q9GZU7 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11953542 | 0.94 | MCL1 (0.45) | THRBCA2L3MBTL1LPLLIPG | |
| SCHEMBL9671868 | 0.87 | HIF1A (0.37) | THRBCA2ALDH1A1 | |
| SCHEMBL8161742 | 0.86 | ALDH1A1 (0.52) | THRBCA2PLK1ALDH1A1TSHR | |
| SCHEMBL28578535 | 0.86 | TSHR (0.48) | THRBCA2L3MBTL1LPLLIPG | |
| SCHEMBL910428 | 0.86 | TAAR1 (0.50) | CA2L3MBTL1LPLLIPGMGLL | |
| SCHEMBL1781293 | 0.85 | THRB (0.39) | THRBCA2L3MBTL1LPLLIPG | |
| SCHEMBL5252411 | 0.85 | ESR1 (0.53) | THRBCA2LPLLIPGALDH1A1 | |
| SCHEMBL2554463 | 0.83 | THRB (0.48) | THRBCA2L3MBTL1LPLLIPG | |
| SCHEMBL15189293 | 0.83 | ESR1 (0.57) | THRBLPLLIPGMGLLALDH1A1 | |
| SCHEMBL97214 | 0.83 | CNR1 (0.38) | LPLLIPGALDH1A1KMT2ACNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | disclosed |
| CN-108368102-A | 2- amino -1,3,4- thiadiazines and antifungal agent based on 2- amino -1,3,4- oxadiazines | F2G有限公司 | 2018-08-03 | — | — | CN | disclosed |
| US-8937090-B2 | Parakeratosis inhibitor, pore-shrinking agent and external composition for skin | SHISEIDO COMPANY, LTD. (JP) | 2015-01-20 | — | — | US | disclosed |
| EP-2322495-B1 | Novel 4-alkyl cyclohexanepropanal compounds and their use in perfume compositions | INT FLAVORS & FRAGRANCES INC (US) | 2013-01-02 | — | — | EP | disclosed |
| EP-2322495-B1 | Novel 4-alkyl cyclohexanepropanal compounds and their use in perfume compositions | INT FLAVORS & FRAGRANCES INC (US) | 2013-01-02 | — | — | EP | disclosed |
| US-20120232111-A1 | Parakeratosis inhibitor, pore -shrinking agent and external compositon for skin | SHISEIDO COMPANY, LTD. (JP) | 2012-09-13 | — | — | US | disclosed |
| US-20120165409-A1 | WRINKLE-IMPROVING AGENT | SHISEIDO COMPANY, LTD. (JP) | 2012-06-28 | — | — | US | disclosed |
| EP-2333038-B1 | Novel 4-Alkyl Cyclohexanepropanal Compounds and their use in Perfume Compositions | INT FLAVORS & FRAGRANCES INC (US) | 2012-06-13 | — | — | EP | disclosed |
| EP-2333038-B1 | Novel 4-Alkyl Cyclohexanepropanal Compounds and their use in Perfume Compositions | INT FLAVORS & FRAGRANCES INC (US) | 2012-06-13 | — | — | EP | disclosed |
| EP-2322495-A1 | Novel 4-alkyl cyclohexanepropanal compounds and their use in perfume compositions | International Flavors & Fragrances Inc. (US) | 2011-05-18 | — | — | EP | disclosed |
| US-20110004019-A1 | Parakeratosis Inhibitor, Pore-Shrinking Agent, Or Rough Skin Inhibiting/Ameliorating Agent, And External Composition For Skin Containing The Same | SHISEIDO COMPANY LTD. (JP) | 2011-01-06 | — | — | US | disclosed |
| EP-2255780-A1 | PARAKERATOSIS INHIBITOR, PORE SHRINKING AGENT OR AGENT FOR PREVENTING OR IMPROVING ROUGH SKIN, AND COMPOSITION FOR EXTERNAL USE ON THE SKIN CONTAINING THE SAME | Shiseido Company, Ltd. (JP) | 2010-12-01 | — | — | EP | disclosed |
| US-7834219-B1 | 4-alkyl cyclohexanepropanal compounds and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2010-11-16 | — | — | US | disclosed |
| US-7834219-B1 | 4-alkyl cyclohexanepropanal compounds and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2010-11-16 | — | — | US | disclosed |
| US-7834219-B1 | 4-alkyl cyclohexanepropanal compounds and their use in perfume compositions | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2010-11-16 | — | — | US | disclosed |
| US-20100035881-A1 | WRINKLE-IMPROVING AGENT | SHISEIDO COMPANY, LTD. (JP) | 2010-02-11 | — | — | US | disclosed |
| EP-1941861-A1 | WRINKLE-IMPROVING AGENT | Shiseido Company, Limited (JP) | 2008-07-09 | — | — | EP | disclosed |
| EP-1880711-A1 | PARAKERATOSIS INHIBITOR, PORE-SHRINKING AGENT AND EXTERNAL COMPOSITION FOR SKIN | Shiseido Company, Limited (JP) | 2008-01-23 | — | — | EP | disclosed |
| US-6077318-A | TREATING SURFACE WITH NONSTAINING AQUEOUS SOLUTION CONTAINING PERFUME AND LOW LEVELS OF CYCLODEXTRIN DERIVATIVE AND LOW MOLECULAR WEIGHT MONOHYDRIC ALCOHOLS | THE PROCTER & GAMBLE COMPANY (US) | 2000-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100035881-A1 | WRINKLE-IMPROVING AGENT | AAAS, GLA, COL14A1 | THRB 3520/4885CA2 2941/4885L3MBTL1 874/4885 |
| US-20120232111-A1 | Parakeratosis inhibitor, pore -shrinking agent and external compositon for skin | CUTA, AAAS, NUP160 | THRB 2937/4885CA2 876/4885L3MBTL1 1100/4885 |
| US-20110004019-A1 | Parakeratosis Inhibitor, Pore-Shrinking Agent, Or Rough Skin Inhibiting/Ameliorating Agent, And External Composition For Skin Containing The Same | CUTA, GLRA3, ARGLU1 | THRB 3509/4885CA2 1017/4885L3MBTL1 3695/4885 |
| US-20120165409-A1 | WRINKLE-IMPROVING AGENT | AAAS, GLA, COL14A1 | THRB 3373/4885CA2 3261/4885L3MBTL1 999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.